Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05263752 · ClinicalTrials.gov registry record
Evaluation of Safety and Efficacy of NvisionVLE® Imaging Low Profile System in Patients With Bile Duct Disease
A clinical trial, sponsored by Methodist Health System.
- Completed
- Registry status
- 3
- Enrollment target
NCT05263752 is a clinical trial that has completed, run by Methodist Health System. The registered enrollment target is 3 participants.
The verdict
NCT05263752 has completed, sponsored by Methodist Health System.
- COMPLETED
- Registry status
- 3 participants
- Enrollment target
Study Summary
A previous study evaluating the NvisionVLE® Imaging Low Profile System revealed the system to be feasible and safe for use in bile duct. The study also revealed a potential to better define abnormalities, target sampling and therapy when utilizing the NvisionVLE® Imaging Low Profile System. This study will further evaluate the safety and efficacy of the NvisionVLE® Imaging Low Profile System in patients with bile duct diseases.
Interventions
- DEVICE ERCP with NvisionVLE® Imaging Low Profile System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2017-10-18 |
| Est. Completion | 2020-06-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05263752
The ClinicalTrials.gov registry entry for NCT05263752 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 3 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Methodist Health System, which has 125 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which ERCP with NvisionVLE® Imaging Low Profile System is the first listed.
NCT05263752 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05263752 about?
NCT05263752 is a clinical study titled "Evaluation of Safety and Efficacy of NvisionVLE® Imaging Low Profile System in Patients With Bile Duct Disease". A previous study evaluating the NvisionVLE® Imaging Low Profile System revealed the system to be feasible and safe for use in bile duct. The study also revealed a potential to better define abnormalities, target sampling and therapy when utilizing the NvisionVLE® Imaging Low Profile System. This stu...
What is the current status of trial NCT05263752?
This trial is currently completed. The enrollment target is 3 participants. The study started on 2017-10-18. Estimated completion is 2020-06-30.
What interventions are being tested in trial NCT05263752?
The interventions under investigation include: ERCP with NvisionVLE® Imaging Low Profile System (DEVICE).
Who is sponsoring clinical trial NCT05263752?
This trial is sponsored by Methodist Health System, which has 125 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.